(48 days)
Not Found
No
The device description and performance studies focus on chemical cleaning solutions and their comparison to predicate devices, with no mention of AI or ML technologies.
No.
The device is a protein remover for contact lenses and is not applied to the human body for therapeutic purposes.
No
The device is a protein remover for contact lenses and does not perform any diagnostic function. Its purpose is cleaning, not diagnosis.
No
The device description clearly states it is a mixture of two sterile solutions and a vial, indicating it is a chemical and hardware product, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to clean and remove protein deposits from contact lenses. This is a cleaning and maintenance product for a medical device (contact lenses), not a diagnostic test performed on a biological sample from the human body.
- Device Description: The description details a chemical solution used to clean contact lenses. It doesn't involve analyzing biological samples like blood, urine, or tissue.
- Lack of Diagnostic Information: There is no mention of the device being used to diagnose, monitor, or predict any disease or condition.
- Over-The-Counter Use: While some IVDs can be OTC, the primary function of this product is not diagnostic.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This product does not fit that description.
N/A
Intended Use / Indications for Use
Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses, when used as directed, cleans and removes protein deposits from fluorosilicone acrylate rigid gas permeable contact lenses.
Product codes (comma separated list FDA assigned to the subject device)
MRC
Device Description
Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses is the mixture of two sterile solutions, Progent A (active ingredient, sodium hypochlorite) and Progent B (active ingredient, potassium bromide). Progent A and B are mixed in a Progent Vial. Menicon Rinse solution is used once the lens soaking cycle is complete. The Progent treatment is recommended every two weeks. The frequency may vary according to the condition of your lens. Follow your eye care professional's directions (to a maximum of every 5 days).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Over-The-Counter Use (21 CFR 801 Subpart C)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Data: Non-clinical studies were unnecessary for this application. Menicon Progent Protein Remover has been cleared in prior applications. There are no product formulation changes made in this application therefor no non-clinical studies were required.
Clinical Data: Clinical studies were unnecessary for this application. Menicon Progent Protein Remover has been cleared in prior applications. There are no product formulation changes made in this application therefor no clinical studies were required.
Conclusion: Based upon the product history and data presented, the Menicon Progent Protein Remover can be used as safely and as effectively as the Boston Cleaner and the Boston Advance Cleaner.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 886.5918 Rigid gas permeable contact lens care products.
(a)
Identification. A rigid gas permeable contact lens care product is a device intended for use in the cleaning, conditioning, rinsing, lubricating/rewetting, or storing of a rigid gas permeable contact lens. This includes all solutions and tablets used together with rigid gas permeable contact lenses.(b)
Classification. Class II (Special Controls) Guidance Document: “Guidance for Industry Premarket Notification (510(k)) Guidance Document for Contact Lens Care Products.”
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services seal on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name, "U.S. Food & Drug Administration," written out in a clear, sans-serif font.
November 16, 2017
Menicon Co., Ltd. % Ellen Beucler Vice President Foresight Regulatory Strategies, Inc. 187 Ballardvale Street, Suite A250 Wilmington, MA 01887
Re: K173136
Trade/Device Name: Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses Regulation Number: 21 CFR 886.5918 Regulation Name: Rigid Gas Permeable Contact Lens Care Products Regulatory Class: Class II Product Code: MRC Dated: September 28, 2017 Received: September 29, 2017
Dear Ellen Beucler:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies.
1
You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Denise L. Hampton -S
for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K173136
Device Name
Menicon Progent Protein Remover
Indications for Use (Describe)
Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses, when used as directed, cleans and removes protein deposits from fluorosilicone acrylate rigid gas permeable contact lenses.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | |
| Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/2 description: The image shows the text "Menicon Co., Ltd." in a bold, sans-serif font. The text is arranged on a single line, with the company name followed by the abbreviation "Co." and "Ltd.". The text is black against a white background.
510(k) Summary Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses
1. Applicant Information
Menicon Co., Ltd.
| Contact Person: | Kenichi Tanaka |
|---|---|
| Telephone No.: | +81-52-935-1676 |
| Fax No .: | +81-52-935-1633 |
| E-mail: | kenichi-tanaka@menicon.co.jp |
| Date Prepared: | November 7, 2017 |
2. Device Information
| Proprietary name: | Menicon Progent Protein Remover |
|---|---|
| Device classification: | Class II |
| Common Name: | RGP Contact Lens Care Product |
| Classification name: | RGP Contact Lens Care Product |
| Regulation number: | 21 CFR 886.5918 |
| Product code: | MRC |
3. Predicate Devices
The predicate devices are the RGP contact lens cleaners, Boston Cleaner (P860029) and Boston Advance Cleaner (K923437 and K974466). These products are sold over the counter without prescription.
4. Description of Device
Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses is the mixture of two sterile solutions, Progent A (active ingredient, sodium hypochlorite) and Progent B (active ingredient, potassium bromide). Progent A and B are mixed in a Progent Vial. Menicon Rinse solution is used once the lens soaking cycle is complete. The Progent treatment is recommended every two weeks. The frequency may vary according to the condition of your lens. Follow your eye care professional's directions (to a maximum of every 5 days).
Image /page/3/Picture/13 description: The image shows a logo with a red semi-circle on top and a green semi-circle on the bottom. A white line runs through the middle of the circle, creating a wave-like pattern. The logo is simple and modern, with a focus on color and shape.
4
5. Indications for Use
Menicon Progent Protein Remover for Rigid Gas Permeable Contact Lenses, when used as directed, cleans and removes protein deposits from fluorosilicone acrylate RGP contact lenses.
6. Performance Data
Non-Clinical Data
Non-clinical studies were unnecessary for this application. Menicon Progent Protein Remover has been cleared in prior applications. There are no product formulation changes made in this application therefor no non-clinical studies were required.
Clinical Data
Clinical studies were unnecessary for this application. Menicon Progent Protein Remover has been cleared in prior applications. There are no product formulation changes made in this application therefor no clinical studies were required.
Conclusion
Based upon the product history and data presented, the Menicon Progent Protein Remover can be used as safely and as effectively as the Boston Cleaner and the Boston Advance Cleaner.
7. Substantial Equivalence
The claim of substantial equivalence to the previously approved Boston Cleaner and cleared Boston Advance Cleaner for rigid gas permeable contact lenses is based on the fact that both products are contact lens cleaners for rigid gas permeable contact lenses and when used as directed, can be used safely and effectively to remove protein deposits from the surface of rigid contact lens materials.
5
Table 1 Device Comparison
| Menicon Progent | Boston Cleaner | Boston Advance | |
|---|---|---|---|
| Product Code | MRC | LPN, MRC | LPN, MRC |
| Class | II | II | II |
| Regulation Number | 21 CFR 886.5918 | 21 CFR 886.5918 | 21 CFR 886.5918 |
| Action | Cleans and removes protein | ||
| deposits from contact lenses | Cleans and removes deposits | ||
| from contact lenses | Cleans and removes deposits | ||
| from contact lenses | |||
| Indicated for | RGP Contact Lenses | RGP Contact Lenses | RGP Contact Lenses |
| Primary Container | Plastic resin container with twist | ||
| off cap | Plastic resin container with | ||
| screw cap | Plastic resin container with | ||
| screw cap | |||
| Container | Single Use | Multi Use | Multi Use |
| Sterile | Yes | Yes | Yes |